LIPT1, an enzyme that activates 2-ketoacid dehydrogenases related to the TCA cycle and promotes cuproptosis (Solmonson and DeBerardinis, 2018), has been reported the association with the prognosis of urothelial carcinoma and lung cancer in the Pathology Atlas project (Uhlen et al., 2017). Here, LIPT1 is linked to lung cancer.